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ABSTRACT
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide abundantly expressed in the
central nervous system and involved in regulating neurogenesis and neuronal signal transduction. The amino
acid sequence of PACAP is extremely conserved across vertebrate species, indicating a strong functional
constraint during the course of evolution. However, through comparative sequence analysis, we demonstrated
that the PACAP precursor gene underwent an accelerated evolution in the human lineage since the
divergence from chimpanzees, and the amino acid substitution rate in humans is at least seven times
faster than that in other mammal species resulting from strong Darwinian positive selection. Eleven human-
specific amino acid changes were identified in the PACAP precursors, which are conserved from murine
to African apes. Protein structural analysis suggested that a putative novel neuropeptide might have
originated during human evolution and functioned in the human brain. Our data suggested that the
PACAP precursor gene underwent adaptive changes during human origin and may have contributed to
the formation of human cognition.
HUMANS diverged from African apes5–7 million Pituitary adenylate cyclase-activating polypeptide (PA-years ago (Goodman et al. 1998). Genetically, hu- CAP) is a well-studied neuropeptide that plays a pivotal
mans and chimpanzees share nearly 99% DNA sequence role in the central nervous system by acting as a neuro-
similarity (Fujiyama et al. 2002; Hellmann et al. 2003; hormone and a neurotransmitter (Dicicco-Bloom et al.
Shi et al. 2003), which seems to contradict the marked 1998; Montero et al. 2000; Vaudry et al. 2000; Hamelink
biological divergence between them, e.g., the highly de- et al. 2002; Moretti et al. 2002). In the human genome,
veloped cognitive abilities in humans. Therefore, the the gene encoding the PACAP precursor (ADCYAP1) is
major challenge in the rapidly progressing human and located on chromosome 18p11 (Hosoya et al. 1992). This
chimpanzee genome comparison studies is to deter- region was shown to be related with holoprosencephaly,
mine the small subset of sequence differences that have the most common hereditary development defect of the
phenotypic significance related to species-specific traits forebrain in humans (a single-lobed brain structure with
(Enard et al. 2002; Stedman et al. 2004). Recent studies severe skull and facial defects) (Golden 1998). Recent
on FOXP2 and myosin demonstrated that the human- studies showed that PACAP is involved in cerebral corti-
specific substitutions in these two genes are related to cal neurogenesis by eliciting the transition from prolifer-
the phenotypic divergence between humans and nonhu- ation to differentiation in cortical precursors (Dicicco-
man primates, i.e., the acquiring of language ability and Bloom et al. 1998; Suh et al. 2001). Gene knockout studies
gracilization of masticatory muscles relevant to accelerated in mouse revealed altered psychomotor behaviors (Has-
encephalization during human evolution (Enard et al. himoto et al. 2001). The PACAP homolog in Drosoph-
2002; Zhang et al. 2002; Stedman et al. 2004).
ila, amnesiac (amn), was shown to be crucial in adult mem-
ory formation (DeZazzo et al. 1999).
The human PACAP precursor gene (ADCYAP1) hasSequence data from this article have been deposited with the EMBL/
GenBank Data Libraries under accession nos. AY592934–AY592953. five exons encoding a protein of 176 amino acids with
1Corresponding author: Key Laboratory of Cellular and Molecular PACAP located in the C-terminal region (Figure 1)
Evolution, Kunming Institute of Zoology, Chinese Academy of Sci- (Hosoya et al. 1992). PACAP has two forms, the 38-ences, 32 Jiao-Chang-Dong-Lu, Kunming, Yunan 650223, China.
E-mail: sub@mail.kiz.ac.cn amino-acid form (PACAP38) and the 27-amino-acid
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the transition and transversion bias was taken into accountform (PACAP27), which are generated through post-
(Li 1993; Pamilo and Bianchi 1993). On the basis of resultstranslational processing by the precursor convertase
from the Pamilo-Bianchi-Li analysis, which suggested that the
(Vaudry et al. 2000). The sequence of PACAP has been human lineage has an accelerated evolution, we elected to
remarkably conserved in vertebrates during evolution run a likelihood-ratio test to compare two alternative models
of sequence evolution: a model in which rates of dN/d S ()and no amino acid substitution was observed in the
are constrained to be equal vs. a model in which the humanmammal species studied so far (Montero et al. 2000)
lineage is assumed to have a different rate from the other(Figure 1).
lineages (Yang 1998). The relative rate test was used to detect
In this study, we sought to understand the molecular amino acid substitution rate variations in different primate
history of the PACAP precursor gene in primates and lineages (Tajima 1993). The McDonald-Kreitman test was con-
ducted to detect positive selection by comparing the between-other vertebrate species. Our results demonstrate an
species nonsynonymous/synonymous substitution ratios withaccelerated evolution of the PACAP precursor in the
the within-species nonsynonymous/synonymous polymor-lineage leading to the emergence of humans, which
phism ratios (McDonald and Kreitman 1991). The protein
is likely caused by Darwinian positive selection during structure analysis was conducted by utilizing the tools (the
human evolution. PROSITE SCAN package) from the ExPASy Molecular Biology
Server hosted by the North Carolina Supercomputing Center
(http://us.expasy.org/).
MATERIALS AND METHODS
The human DNA samples in this study are from three major RESULTS AND DISCUSSION
continental populations, including 30 Han Chinese (Kun-
ming, China), 10 Europeans (Italy), and 10 Africans (Central In the effort to identify the fast-evolving genes in the
African Republic Pygmy and Ethiopian). We also sampled five human genome, we observed rapid amino acid substitu-
nonhuman primate species (see Figure 1 for details). All the tions between humans and chimpanzees in the PACAP
human and nonhuman primate samples were from the collec-
precursor gene. A total of 17 amino acid substitutionstions of the Kunming Cell Bank, the Chinese Academy of
(9.7%, 17/176) were detected in the human PACAPSciences, and Stanford University.
The PCR primers were designed on the basis of the sequence precursor, which is much higher than the average pro-
alignment of human and other available mammalian species tein sequence divergence (1.0%) between humans and
(Ensemble genome browser at http://www.ensemble.org and chimpanzees (Fujiyama et al. 2002; Hellmann et al.
http://pre.ensembl.org/Pan_troglodytes/). The primer se-
2003; Shi et al. 2003) (Figure 1). Surprisingly, whenquences are:
the human and chimpanzee protein sequences were
NM001117_E1F, 5-CAAGTGCTGTTCAACTCAGGGA-3; aligned with those of other mammalian species, 11 of
NM001117_E1R, 5-GGCGATGCTAGTAGTCTGGACC-3; the 17 amino acid substitutions were found conservedNM001117_E2F, 5-GAGACAATTCTCAGCGGAGGAC-3;
in mouse, rat, and sheep (Figure 1), indicating that theNM001117_E2R, 5-GCCACTCACTGCCACTCTTTG-3;
accelerated evolution of the PACAP precursor occurredNM001117_E3F, 5-GGGAGTTATTGGCGAGTTCTG-3;
NM001117_E3R, 5-AAAATCTCCAACTGCGACCC-3; only in the human lineage. The same conserved substitu-
NM001117_E4F, 5-GCGGCGATTGAATCTGTGTCTC-3; tion pattern was observed when we sequenced four other
NM001117_E4R, 5-GAACACATGAGCGATGACTGTTGAG-3; nonhuman primate species (one sample from each spe-NM001117_E4F2, 5-CTCCAGGGCAGCAGCCAGAC-3;
cies), including gorilla (Gorilla gorilla), orangutan (PongoNM001117_E4R2, 5-ACAGCTCGGGCGAATTTTCAA-3;
pygmaeus), gibbon (Hylobates hoolock), and rhesus mon-NM001117_I2F, 5-GATCCTATTGCAGCGACAGAAAA-3;
NM001117_I3R, 5-CGTGAAGATCCCGTCCGAGTG-3; key (Macaca mulatta), which have varied degrees of di-
NM001117_I3F, 5-TGGGGTAAGAGTTTGTGGAAGG-3. vergence from humans (7–25 million years) (Goodman
et al. 1998) (Figures 1 and 2).All the human and nonhuman primate samples were se-
quenced for the 531-bp coding region of the PACAP precursor To see if the amino acid substitutions are fixed in hu-
gene (exons 2–5; exon 1 is nontranslational). A 400-bp fragment man populations, we sequenced 50 human individuals
of intron 3 was sequenced in 30 humans (10 samples from each (100 chromosomes) from the major continental popula-
of the three continental populations) and six chimpanzees. The
tions, including 30 Han Chinese, 10 Europeans, andsequences from the other mammalian and vertebrate species
10 Africans. All the amino acid substitutions observedwere from published data (accession nos. NM_009625, NM_
016989, S83511, U67275, AF187877, AF329730; NCBI at http:// between human and nonhuman primates were con-
www.ncbi.nlm.nih.gov/). served in the human populations. There are three poly-
The DNA sequences were aligned using DNASTAR (DNA morphic sites observed in humans; two are silent changes
STAR, Madison, WI), and checked manually. The amino acid
and one a missense (Asp54Gly) (Figure 1). We conductedsequences were aligned using CLUSTAL X ( Jeanmougin et
a phylogenetic analysis to reveal the detailed mutational. 1998). The phylogenetic relationships among the primate
species tested were based on the published data (Goodman patterns in different evolutionary lineages (Figure 2). The
et al. 1998). The ancestral sequences (internal nodes) in the synonymous (silent) and nonsynonymous (missense)
phylogenetic tree (Figure 2) were inferred by using the ANC- substitution rates (K s and K a , respectively) were calcu-GENE program developed by Zhang et al. (1998). With the
lated following Pamilo-Bianchi-Li’s method (Li 1993;use of MEGA2.0 program (Kumar et al. 2001), the Pamilo-
Pamilo and Bianchi 1993). As shown in Figure 2 andBianchi-Li method was employed to estimate the nonsynony-
mous and synonymous substitution ratios (K a/K s), in which Table 1, when the unidentified domain (UD) and PA-
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CAP-related peptide (PRP) (Vaudry et al. 2000) regions
were considered, the human lineage had a large K a/K s
ratio (K a/K s  3.28, P 0.026, one-tailed z-test). Similar
results were observed when calculating the  (dN/d S)
values using the maximum-likelihood method devel-
oped by Yang (1998; data not shown). The likelihood-
ratio test indicated that the human lineage has a sig-
nificantly larger -value than the nonhuman primate
lineages (2LnL  9.14, P  0.003; Yang 1998), re-
flecting a rapid evolution of the human PACAP precur-
sor. In contrast, all the other lineages, including that
of the chimpanzee, had very small K a/K s ratios with most
of them following the expectation of negative selection
(functional constraint) (K a/K s  1). When the entire
coding region of the PACAP precursor gene is consid-
ered, the K a/K s ratio in the human lineage is 1.37, which
is still significantly larger than that of the nonhuman
primate lineages according to the likelihood-ratio test
(2LnL 7.90, P 0.005; Yang 1998), again indicating
the rapid amino acid substitution rate in the human
lineage (Figure 1 and Table 1). The amino acid substitu-
tion rate in the human lineage is at least seven times
faster than those of the other mammalian lineages (3.4
vs. 0–0.45 amino acid substitutions/gene/million years),
and the relative rate test based on protein sequences
showed a significant rate difference between humans
and chimpanzees (P  0.001) (Tajima 1993).
The rapid evolution of the human PACAP precursor
can be due to either Darwinian positive selection or
relaxation of functional constraint. To further test
whether positive selection or relaxation of functional
constraint is responsible for the observed rapid evolu-
tion of the PACAP precursor in the human lineage, we
conducted the neutrality test following McDonald and
Kreitman (1991). To obtain enough polymorphic sites
in human populations (only three polymorphic sites
were observed in the coding region), we sequenced the
upstream segment of intron 3 (400 bp) of the PACAP
precursor gene in 30 humans (10 samples from each
continental population) and six chimpanzees. A total
of seven polymorphic sites were observed in humans
while no polymorphism was found in the chimpanzees.
If there is positive selection in the human lineage, the
ratio of nonsynonymous/synonymous substitutions be-
tween human and chimpanzee (17.5/20.5) should be
significantly higher than the ratio of nonsynonymous/
synonymous polymorphisms within human populations
(1/9), which turned out to be the case (P 0.039, one-
tailed Fisher’s exact test) when the intron sequences
were treated as synonymous sites. Hence, the acceler-
ated amino acid substitution rate in the human lineage
was likely caused by adaptive evolution instead of relax-
ation of functional constraint. The substitution rate be-
tween human and chimpanzee at the synonymous sites
(K s  0.056) is slightly larger than that of the intron
region (K i  0.036), but not statistically significant (P F
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0.05, two-tailed Fisher’s exact test); therefore, the use
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Figure 2.—The K a/K s ratios of different evo-
lutionary lineages. The calculations were based
on the data from the UD and PRP domains
only. The Pamilo-Bianchi-Li method was used
in estimating the K a/K s ratios (Li 1993; Pamilo
andBianchi 1993). The numbers in parenthe-
ses refer to the numbers of nonsynonymous
and synonymous substitutions. The divergence
times between human and other mammal spe-
cies are indicated (myrs, million years) (Hedges
and Kumar 1999).
of intron sequences would not bring much bias in the from enzymatic degradation (half-life) and increase bind-
ing affinity to the receptors (Eipper et al. 1992). Therefore,McDonald and Kreitman test.
The human-specific substitutions are located in the as only humans have the potential -amidation site, the
41-aa putative novel peptide may exist and functioncentral region of the PACAP precursor, in contrast to
the highly conserved PACAP region (Figure 1). The only in humans. When compared with chimpanzees,
the putative novel peptide in humans acquired 12 aminofixed substitutions in humans resulted in three potential
protein motif changes by gaining an -amidation site acid substitutions (29.3%, 12/41), which is consistent
with the proposed strong positive selection on the UD(Gly79) and a N-myristoylation site (Gly122) while losing
a protein kinase C phosphorylation site (Gly102) (Table region that led to the creation of a novel peptide during
human evolution. However, functional data need to be2). The gain of the -amidation site is particularly intri-
guing because previous studies showed that the C-termi- generated to confirm the existence and the biological
function of the proposed novel neuropeptide in thenal -amidation is a critical determinant of biologic
activity for neuropeptides, including PACAP (Eipper et human brain.
The PRP region also showed a strong signal of positiveal. 1992), and a putative novel peptide would be ex-
pected in humans due to the gain of the -amidation selection in humans although the statistical test was not
significant (K a/K s  11.35, P  0.067, one-tailed z-test).site. There are seven potential post-translational pro-
cessing sites in the human PACAP precursor, which The two fixed substitutions of PRP (Gly102 and His104)
in humans are conserved in all the other vertebrateare single or pairs of basic amino acids (lysine and/or
arginine) that can be cleaved by precursor convertase species including chicken, Xenopus, and fish (Figure
1). As described above, the Gly102 resulted in the poten-(Seidah et al. 1998; Vaudry et al. 2000) (Figure 1). The
mutation at site Gly79 provided a novel putative tial loss of a protein kinase C phosphorylation site in
humans, implying that the human PRP might acquire-amidation site in humans, which may create a bioac-
tive peptide of 41 amino acids (sites 38–78, Figure 1) a modified function during human evolution.
It is generally accepted that human intelligence iswith the following sequence: PEEEAYGEDGNPLPDFD
(G)GSEPPGAGSPASAPRAAAAWYRPA-NH2. the product of adaptive evolution (Dunbar 1998). The
enlarged brain and highly developed cognitive abilitiesThe -amidation of neuropeptides can protect them
TABLE 1
The calculation of the K a/K s ratios in the human and chimpanzee lineages
Human node A Chimpanzee node A
z-test z-test z-test z-test
Gene domain K a/K s positive negative K a/K s positive negative
UD 2.61 0.085 1.000 0 1.000 0.176
PRP 11.35 0.067 1.000 NA NA NA
UD and PRP 3.28 0.026* 1.000 0 1.000 0.166
PACAP 0 1.000 0.104 0 1.000 0.198
Entire gene 1.37 0.261 1.000 0 1.000 0.040*
Node A refers to the common ancestor of humans and chimpanzees (Figure 2). The z-test was used to detect
whether the ratios of K a/K s deviate statistically from 1, the neutral expectation. The probabilities (P) of one-
tailed z-tests for positive and negative selection (z-test positive and z-test negative) are listed. *Significant
P-values (P  0.05). NA, not applicable (K a  0).
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TABLE 2
Protein motif comparison between human and other mammalian species
Nonhuman
Location Motif Human primates Mouse Rat Sheep
-Amidation site
78–81 AGRR Yes No No No No
Protein kinase C phosphorylation site
100–102 SAR No Yes Yes Yes Yes
N-Myristoylation site
118–123 GGGAGD Yes No No No No
The underlined sites are those human-specific substitutions causing protein motif changes. The protein
structure analysis was conducted by utilizing the tools from the ExPASy Molecular Biology Server hosted by
the North Carolina Supercomputing Center (http://us.expasy.org/).
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